Elan's Zonegran approved

ELN received FDA marketing approval for Zonegran zonisamide anti-convulsant capsules as an adjunctive therapy to treat partial seizures in adults with epilepsy. The product was developed by Dainippon (Osaka, Japan), and ELN holds North American and European marketing rights. ...